B Biocentis 2025-11-18 $19 million Summary Biocentis, a London-based company specializing in genetic insect control, has raised $19 million to transition from R&D to real-world deployments, per Axios. Investors The Grantham FoundationNeuroneCorbitesNovaTerra Categories Biotech Source Axios